Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP702220.RAA2ox3KLeEGg48KiHBOKkxt7TQ7juICRQCiqTocIpeyE130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702220.RAA2ox3KLeEGg48KiHBOKkxt7TQ7juICRQCiqTocIpeyE130_provenance.
• NP919285.RAu68Sp2PCdLFCR50DRZ57Teq_kJBIm9ePrUlSHTLBdeg130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919285.RAu68Sp2PCdLFCR50DRZ57Teq_kJBIm9ePrUlSHTLBdeg130_provenance.
• NP794762.RAyc3GW9BWKKazCSLwGbLok_rBB7kFaPj-LtOAMczzT_E130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794762.RAyc3GW9BWKKazCSLwGbLok_rBB7kFaPj-LtOAMczzT_E130_provenance.
• NP851634.RAWikN2l-GT0gwx9mq2D1XqXJ1qH59zTW0LZ4UGpMHZgU130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851634.RAWikN2l-GT0gwx9mq2D1XqXJ1qH59zTW0LZ4UGpMHZgU130_provenance.
• NP891467.RA0mmQHccVGcacNYQLxwHqZtBxp1I5LK4RNU5O8rPjF74130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891467.RA0mmQHccVGcacNYQLxwHqZtBxp1I5LK4RNU5O8rPjF74130_provenance.
• NP805321.RAWfcm7J8VKT_JQpNacCzxMFS4PYGeyj-P-MXLLkdcIJ0130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805321.RAWfcm7J8VKT_JQpNacCzxMFS4PYGeyj-P-MXLLkdcIJ0130_provenance.
• NP653611.RAyhqXjdogdzJtWYgo3lfWCgo_OgDkdKeB-yJVjWZvBhM130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653611.RAyhqXjdogdzJtWYgo3lfWCgo_OgDkdKeB-yJVjWZvBhM130_provenance.
• NP653612.RAIWjDwtFi6zkMfLI9R9TlvyUe33BpLFAud2zUEKY5Tsk130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653612.RAIWjDwtFi6zkMfLI9R9TlvyUe33BpLFAud2zUEKY5Tsk130_provenance.
• NP653608.RAsWIeruQ4TArEibCigm1Y91hseYAl1P6wtpmNzJXvDV8130_assertion description "[Recently we have proposed a strategy for the detection of minimal residual disease (MRD) based on the isolation of clonospecific probes following the in vitro amplification of V delta 1 DJ delta 1 junctions by polymerase chain reaction (PCR) and now have adapted this method to the preparation of specific V delta 2 D delta 3 fragments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653608.RAsWIeruQ4TArEibCigm1Y91hseYAl1P6wtpmNzJXvDV8130_provenance.